Abiopharma

Register of shareholders, changes and share capital status - cancellation of dormant shares

Q2 2026 results presentation

A dividend in the amount of 540.97968 agorot per share, record date 27.8.26, payment 3.9.26

The company’s liability position as of 30.6.26, by repayment dates

Presentation to the capital market summarizing the second quarter of 2026

Change/cancellation of a purchase plan

Change/cancellation of a purchase plan

The company’s outstanding liabilities as of June 30, 2026, by repayment dates

Q2 / Semi-annual report for 2026

Events and transactions

Management and officers – staffing as of 19.8.26

Events and transactions

Q2 report for 2026 - iXBRL report

Q2/half-year report for 2026

dividend